Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/106916/1/phar1392.pd
Aim: The aim of this study is to compare the therapeutic yield of medical thoracoscopy and intrapleu...
Aims: To gather data on the clinical presentation of parapneumonic effusion and empyema and to exami...
Urokinase is an enzyme with a fibrinolytic effect that facilitates pleural empyema drainage through ...
SummaryBackgroundIntrapleural recombinant tissue plasminogen activator (r-TPA) has been successfully...
In this paper, we describe our experience in the treatment of childhood empyema using urokinase. Pat...
Stevens A, Tobias JD. Tissue plasminogen activator as adjunctive therapy of empyema in a child. J In...
The authors retrospectively review the clinical course and outcome of 6 pediatric patients, ranging ...
Background: A randomized controlled trial of adults with empyema recently demonstra...
Considerable heterogeneity exists in the management of parapneumonic pleural disease. A randomized c...
Intrapleural urokinase has been shown to be effective in the treatment of pleural effusions in child...
AbstractAimThe aim of this study is to compare the therapeutic yield of medical thoracoscopy and int...
We studied 80 children with parapneumonic effusion (PPE) with respect to the clinical manifestations...
Background: The role of intrapleural fibrinolytic agents in the treatment of childhood empyema has n...
SummaryPatients with pleural infections have a high risk of morbidity and mortality with prolonged h...
Background. Childhood pneumonia is common in all countries, and empyema is one of the commonest comp...
Aim: The aim of this study is to compare the therapeutic yield of medical thoracoscopy and intrapleu...
Aims: To gather data on the clinical presentation of parapneumonic effusion and empyema and to exami...
Urokinase is an enzyme with a fibrinolytic effect that facilitates pleural empyema drainage through ...
SummaryBackgroundIntrapleural recombinant tissue plasminogen activator (r-TPA) has been successfully...
In this paper, we describe our experience in the treatment of childhood empyema using urokinase. Pat...
Stevens A, Tobias JD. Tissue plasminogen activator as adjunctive therapy of empyema in a child. J In...
The authors retrospectively review the clinical course and outcome of 6 pediatric patients, ranging ...
Background: A randomized controlled trial of adults with empyema recently demonstra...
Considerable heterogeneity exists in the management of parapneumonic pleural disease. A randomized c...
Intrapleural urokinase has been shown to be effective in the treatment of pleural effusions in child...
AbstractAimThe aim of this study is to compare the therapeutic yield of medical thoracoscopy and int...
We studied 80 children with parapneumonic effusion (PPE) with respect to the clinical manifestations...
Background: The role of intrapleural fibrinolytic agents in the treatment of childhood empyema has n...
SummaryPatients with pleural infections have a high risk of morbidity and mortality with prolonged h...
Background. Childhood pneumonia is common in all countries, and empyema is one of the commonest comp...
Aim: The aim of this study is to compare the therapeutic yield of medical thoracoscopy and intrapleu...
Aims: To gather data on the clinical presentation of parapneumonic effusion and empyema and to exami...
Urokinase is an enzyme with a fibrinolytic effect that facilitates pleural empyema drainage through ...
DOI
Add to ORKG